yourstate.us
Home / United States / 21 CFR
21 CFR 201.312

§ 201.312 Magnesium sulfate heptahydrate; label declaration on drug products.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 201.312, § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/85818
Permanent ID
ys:prov:85818@1
SHA-256
80fe586f0748830100889f36bd95a22158062397f7d4d12969a6b1caa547f6b7

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

Magnesium sulfate heptahydrate should be listed on the label of a drug product as epsom salt, which is its common or usual name.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.